ID

21781

Descripción

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00311155

Link

https://clinicaltrials.gov/show/NCT00311155

Palabras clave

Versiones (1)
  1. 30/4/17 30/4/17 -
Subido en

30 de abril de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Essential Hypertension NCT00311155

Inglés

Eligibility Essential Hypertension NCT00311155

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female patients age greater than or equal to 18 years with mild to moderate hypertension.
Descripción

age, hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0020538
pre-treated patients with normal or elevated blood pressure (bp) are eligible to participate if their pre-treatment medication can be withdrawn. at the end of the placebo run-in period sitting systolic bp greater than or equal to 140 and less than 180 mmhg and/or sitting diastolic bp greater than or equal to 90 and less than 110 mmhg at trough.
Descripción

blood pressure, pre treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005823
UMLS CUI [1,2]
C2709094
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
female patients of childbearing potential must not be pregnant or lactating and must be using adequate contraception.
Descripción

pregnancy, breast feeding, contraception

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0700589
patients with serious disorders which may limit the ability to evaluate the efficacy or safety of the test drug(s), including cardiovascular, renal, pulmonary, hepatic, gastrointestinal, endocrine/metabolic, haematological/oncological, neurological and psychiatric diseases.
Descripción

cardiovascular, renal, pulmonary, hepatic, gastrointestinal, endocrine, metabolic, hematological, oncological, neurological, neurological or psychiatric comorbidities

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C0007222
UMLS CUI [3]
C0022658
UMLS CUI [4]
C0024115
UMLS CUI [5]
C0023895
UMLS CUI [6]
C0017178
UMLS CUI [7]
C0014130
UMLS CUI [8]
C0025517
UMLS CUI [9]
C0018939
UMLS CUI [10]
C0027651
UMLS CUI [11]
C0027765
UMLS CUI [12]
C0004936
patients within the last 6 months having a history of myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, heart failure, cerebrovascular accident, or transient ischemic attack.
Descripción

myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, heart failure, cerebrovascular accident, transient ischemic attack

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002965
UMLS CUI [3]
C1532338
UMLS CUI [4]
C0018801
UMLS CUI [5]
C0038454
UMLS CUI [6]
C0007787
patients with clinically significant elevations in laboratory values at screening visit.
Descripción

laboratory values

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0022885
patients with secondary hypertension of any etiology, such as renal disease, pheochromocytoma, or cushing's syndrome.
Descripción

secondary hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0155616
patients with contraindications for olmesartan medoxomil, hydrochlorothiazide, and/or amlodipine besylate.
Descripción

contraindications for olmesartan medoxomil, hydrochlorothiazide or amlodipine besylate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0386393
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0020261
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0051696
Volver a la parte superior de la página

Similar models

Eligibility Essential Hypertension NCT00311155

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age, hypertension
Item
male and female patients age greater than or equal to 18 years with mild to moderate hypertension.
boolean
C0001779 (UMLS CUI [1])
C0020538 (UMLS CUI [2])
blood pressure, pre treatment
Item
pre-treated patients with normal or elevated blood pressure (bp) are eligible to participate if their pre-treatment medication can be withdrawn. at the end of the placebo run-in period sitting systolic bp greater than or equal to 140 and less than 180 mmhg and/or sitting diastolic bp greater than or equal to 90 and less than 110 mmhg at trough.
boolean
C0005823 (UMLS CUI [1,1])
C2709094 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
pregnancy, breast feeding, contraception
Item
female patients of childbearing potential must not be pregnant or lactating and must be using adequate contraception.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
cardiovascular, renal, pulmonary, hepatic, gastrointestinal, endocrine, metabolic, hematological, oncological, neurological, neurological or psychiatric comorbidities
Item
patients with serious disorders which may limit the ability to evaluate the efficacy or safety of the test drug(s), including cardiovascular, renal, pulmonary, hepatic, gastrointestinal, endocrine/metabolic, haematological/oncological, neurological and psychiatric diseases.
boolean
C0009488 (UMLS CUI [1])
C0007222 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0024115 (UMLS CUI [4])
C0023895 (UMLS CUI [5])
C0017178 (UMLS CUI [6])
C0014130 (UMLS CUI [7])
C0025517 (UMLS CUI [8])
C0018939 (UMLS CUI [9])
C0027651 (UMLS CUI [10])
C0027765 (UMLS CUI [11])
C0004936 (UMLS CUI [12])
myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, heart failure, cerebrovascular accident, transient ischemic attack
Item
patients within the last 6 months having a history of myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, heart failure, cerebrovascular accident, or transient ischemic attack.
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C1532338 (UMLS CUI [3])
C0018801 (UMLS CUI [4])
C0038454 (UMLS CUI [5])
C0007787 (UMLS CUI [6])
laboratory values
Item
patients with clinically significant elevations in laboratory values at screening visit.
boolean
C0022885 (UMLS CUI [1])
secondary hypertension
Item
patients with secondary hypertension of any etiology, such as renal disease, pheochromocytoma, or cushing's syndrome.
boolean
C0155616 (UMLS CUI [1])
contraindications for olmesartan medoxomil, hydrochlorothiazide or amlodipine besylate
Item
patients with contraindications for olmesartan medoxomil, hydrochlorothiazide, and/or amlodipine besylate.
boolean
C1301624 (UMLS CUI [1,1])
C0386393 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0020261 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0051696 (UMLS CUI [3,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial